Skip to content

Clinical trials

Phase 2 Cholangiocarcinoma trials in Belgium

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Cholangiocarcinoma Phase: Phase 2 Country / region: Belgium Clear all

11 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20143
20151
20172
20181
20192
20211

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed5
Terminated3
Unknown status2
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
American University of Beirut Medical Center1
Basilea Pharmaceutica1
Erasme University Hospital1
Hoffmann-La Roche1
Incyte Corporation1
Jules Bordet Institute1
PCI Biotech AS1
QED Therapeutics, a BridgeBio company1
Universitair Ziekenhuis Brussel1
Universitaire Ziekenhuizen KU Leuven1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Cholangiocarcinoma11
Pancreatic Neoplasms3
Bile Duct Neoplasms2
Biliary Tract Neoplasms2
Breast Neoplasms2
Carcinoma, Non-Small-Cell Lung2
Colorectal Neoplasms2
Endometrial Neoplasms2
Salivary Gland Neoplasms2
Acrocephalosyndactylia1

Trials

Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.